Tekla Healthcare Investors Stock Analysis

Tekla Stock Analysis Notes

About 28.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. Tekla Healthcare Inv last dividend was issued on the 21st of February 2024. Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. Tekla Healthcare operates under Asset Management classification in the United States and is traded on New York Stock Exchange. To learn more about Tekla Healthcare Investors call Daniel Omstead at 215 405 5700 or check out https://www.teklacap.com/hqh.html.

Tekla Healthcare Inv Investment Alerts

Tekla Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 788.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tekla Healthcare's market, we take the total number of its shares issued and multiply it by Tekla Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Tekla Profitablity

The company has Net Profit Margin of 5.47 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is considered to be average in the sector. In the same way, it shows Net Operating Margin of (0.22) %, which entails that for every $100 of revenue, it lost $0.22.

Management Efficiency

The current Return On Tangible Assets is estimated to decrease to 0.04. The current Return On Capital Employed is estimated to decrease to 0.04. The Tekla Healthcare's current Total Current Assets is estimated to increase to about 8.3 M, while Total Assets are projected to decrease to under 673 M. Tekla Healthcare's management efficiency ratios could be used to measure how well Tekla Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 16th of April 2024, Tekla Healthcare has the Risk Adjusted Performance of (0.06), coefficient of variation of (973.89), and Variance of 0.5838. Tekla Healthcare technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down and collect data for thirteen technical drivers for Tekla Healthcare Investors, which can be compared to its competition. Please validate Tekla Healthcare Inv standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if Tekla Healthcare is priced more or less accurately, providing market reflects its prevalent price of 15.95 per share. Given that Tekla Healthcare Inv has information ratio of (0.18), we advise you to double-check Tekla Healthcare Investors's current market performance to make sure the company can sustain itself at a future point.

Tekla Healthcare Inv Price Movement Analysis

Tekla Healthcare Inv Insider Trading Activities

Tekla Healthcare Predictive Daily Indicators

Tekla Healthcare Corporate Filings

Tekla Healthcare Forecast Models

Tekla Healthcare's time-series forecasting models are one of many Tekla Healthcare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tekla Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tekla Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tekla shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tekla Healthcare. By using and applying Tekla Stock analysis, traders can create a robust methodology for identifying Tekla entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.

Is Tekla Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.